Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomized, Placebo-controlled, Multicenter Trial Evaluating the Efficacy and Safety of Saccharomyces Boulardii CNCM I-745 in Adult Patients With Non-constipated Irritable Bowel Syndrome

NCT07168434 is registered in ClinicalTrials.gov with Biocodex as lead sponsor.

NCT NCT07168434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07168434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomized, Placebo-controlled, Multicenter Trial Evaluating the Efficacy and Safety of Saccharomyces Boulardii CNCM I-745 in Adult Patients With Non-constipated Irritable Bowel Syndrome
Lead sponsor
Biocodex
Phase
Phase 3
Overall status
Recruiting
Start date
October 22, 2025
Completion date
October 11, 2026
Enrollment
406 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

ibs (irritable bowel syndrome), ibs, mixed symptoms, ibs-d (diarrhea-predominant)